One has to wonder who checks the costing that Novartis uses to justify the price of its Kymriah Cancer Drug. What would Robert Koch, Louis Pasteur or Alexander Fleming make of this behaviour?
https://www.bloomberg.com//news/articles/2017-08-30/cancer-breakthrough-heralds-new-era-of-cures-costs-and-choices
CPI Much Better than Expected, Bond Market Reacts Poorly in Big Warning
-
The CPI posted some stellar numbers, but the bond market yawns.
37 minutes ago
No comments:
Post a Comment